On 20th March 2014 ESMA, the European Securities and Markets Authority, has issued an updated Questions and Answers document in relation to the Implementation of the Regulation (EU) No 648/2012 on OTC derivatives, central counterparties and trade repositories (EMIR).

Access to this document may be found through the following Link, however this document is intended to be continuously updated with any questions received by ESMA.

www.csb-advocates.com

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.